Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Interest Expense - Others: 2018-2022

  • Abeona Therapeutics' Interest Expense - Others was N/A to $200,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $67,000 for FY2021, which is 88.83% down from last year.
  • Per Abeona Therapeutics' latest filing, its Interest Expense - Others stood at $200,000 for Q1 2022, which was down 84.93% from $1.3 million recorded in Q3 2020.
  • Abeona Therapeutics' Interest Expense - Others' 5-year high stood at $1.3 million during Q3 2020, with a 5-year trough of $2,000 in Q4 2018.
  • For the 2-year period, Abeona Therapeutics' Interest Expense - Others averaged around $763,500, with its median value being $763,500 (2020).